Therapeutic effect of egualen sodium (KT1-32), a new antiulcer agent, on chronic gastritis induced by sodium taurocholate in rats
スポンサーリンク
概要
- 論文の詳細を見る
- 1996-12-01
著者
-
Kishimoto Shinya
Institute Of Health Sciences Department Of Geriatric Medicine Hiroshima University School Of Medicin
-
Tomiyama Akira
Research Laboratories Kotobuki Pharmaceutical Co. Ltd.
-
Mochizuki Seiichiro
Research Laboratories Kotobuki Pharmaceutical Co. Ltd.
-
MATSUMOTO Makoto
Research Laboratories, Kotobuki Pharmaceutical Co. Ltd.
-
WAKABAYASHI Shuichi
Research Laboratories, Kotobuki Pharmaceutical Co. Ltd.
-
KOSAKAI Kazuhiro
Research Laboratories, Kotobuki Pharmaceutical Co. Ltd.
-
Wakabayashi Shuichi
Research Laboratories Kotobuki Pharmaceutical Co. Ltd.
-
Kosakai Kazuhiro
Research Laboratories Kotobuki Pharmaceutical Co. Ltd.
-
Matsumoto Makoto
Research Institute For Mathematical Sceicnes Kyoto University
-
Matsumoto Makoto
Research Laboratories Kotobuki Pharmaceutical Co. Ltd.
関連論文
- Antihypertensive Effect of Chronic KT3 - 671, a Structurally New Nonpeptide Angiotensin AT_1 - Receptor Antagonist, in Stroke - Prone Spontaneously Hypertensive Rats
- Therapeutic effect of egualen sodium (KT1-32), a new antiulcer agent, on chronic gastritis induced by sodium taurocholate in rats
- Galois Representations on Profinite Braid Groups on Curves(Moduli spaces, Galois representations and L-functions)
- Introduction to the filtered Galois representation theory in $\pi_1(\mathbb{P}^1 - { 0, 1, \infty })^{pro-l}$(Moduli spaces, Galois representations and L-functions)
- Effects of topical application of KT1-32 on transmucosal potential difference and acid secretion in the rat stomach.